Psoriatic disease is a multifaceted disorder, which develops in the skin, its appendages and
joints. Though characterized by different pathogenic background and clinical manifestations …

Purpose This review article serves to assess the consistency of recommendations from
guidelines on biologic agents for psoriasis, based on the quality evaluation of psoriasis …

Background Difficult-to-treat palmoplantar psoriasis has a disproportionately negative
impact on quality of life. Objective We evaluated the efficacy and safety of apremilast in …

BACKGROUND: Psoriasis is a disease of worldwide distribution with a prevalence of 1 to
3%. Nail psoriasis is estimated in 50% of patients with psoriasis, and in the presence of joint …

Background The scalp is a frequent and difficult‐to‐treat localization of psoriasis. Little
evidence exists regarding the use of biologic agents in recalcitrant cases of scalp psoriasis …

Background Ixekizumab has proven efficacy and safety for the treatment of psoriasis in
clinical trials. The aim of this study was to evaluate its effectiveness and safety in routine …

Objective To generate an operational definition to adequately reflect the construct 'Minimal
Disease Activity (MDA)'in psoriasis. Methods A systematic review of domains included in …

Objective To critically analyse and define therapeutic objectives, response to treatment
evaluation and related decisions in psoriasis. Methods Expert consensus meetings, a …

Background Response to treatments in psoriasis can be assessed using the PASI response
50, 75, 90 or 100. Achieving a PASI 100 response would mean a complete resolution of the …

Scalp psoriasis affects approximately 80% of patients with psoriasis and can negatively
impact their quality of life. This post hoc analysis of the VOYAGE 2 Phase III randomized …